The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1alpha is associated with increased risk for prostate cancer
Orr-Urtreger A, Bar-Shira A, Matzkin H et al. The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1alpha is associated with increased risk for prostate cancer. Prostate 2007 67 8 13.
Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma
Kuwai T, Kitadai Y, Tanaka S et al. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol. Rep. 2004 12 1033 1037.
Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer
Vleugel MM, Greijer AE, van der Wall E et al. Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer. Cancer Genet. Cytogenet. 2005 163 168 172.
The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma
Clifford SC, Astuti D, Hooper L et al. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 2001 20 5067 5074.
Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients
Fransen K, Fenech M, Fredrikson M et al. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol. Carcinog. 2006 45 833 840.
Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation
Fu XS, Choi E, Bubley GJ et al. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 2005 63 215 221.